Bromberg William J, Collier Bryan C, Diebel Larry N, Dwyer Kevin M, Holevar Michelle R, Jacobs David G, Kurek Stanley J, Schreiber Martin A, Shapiro Mark L, Vogel Todd R
Memorial Health University Medical Center, Savannah, Georgia 31404, USA.
J Trauma. 2010 Feb;68(2):471-7. doi: 10.1097/TA.0b013e3181cb43da.
Blunt injury to the carotid or vertebral vessels (blunt cerebrovascular injury [BCVI]) is diagnosed in approximately 1 of 1,000 (0.1%) patients hospitalized for trauma in the United States with the majority of these injuries diagnosed after the development of symptoms secondary to central nervous system ischemia, with a resultant neurologic morbidity of up to 80% and associated mortality of up to 40%. With screening, the incidence rises to 1% of all blunt trauma patients and as high as 2.7% in patients with an Injury Severity Score of >or=16. The Eastern Association for the Surgery of Trauma organization Practice Management Guidelines committee set out to develop an EBM guideline for the screening, diagnosis, and treatment of BCVI.
A computerized search of the National Library of Medicine/National Institute of Health, Medline database was performed using citations from 1965 to 2005 inclusive. Titles and abstracts were reviewed to determine relevance, and isolated case reports, small case series, editorials, letters to the editor, and review articles were eliminated. The bibliographies of the resulting full-text articles were searched for other relevant citations, and these were obtained as needed. These papers were reviewed based on the following questions: 1. What patients are of high enough risk, so that diagnostic evaluation should be pursued for the screening and diagnosis of BCVI? 2. What is the appropriate modality for the screening and diagnosis of BCVI? 3. How should BCVI be treated? 4. If indicated, for how long should antithrombotic therapy be administered? 5. How should one monitor the response to therapy?
One hundred seventy-nine articles were selected for review, and of these, 68 met inclusion criteria and are excerpted in the attached evidentiary table and used to make recommendations.
The East Practice Management Guidelines Committee suggests guidelines that should be safe and efficacious for the screening, diagnosis, and treatment of BCVI. Risk factors for screening are identified (see ), screening modalities are reviewed indicating that although angiography remains the gold standard, multi-planar (>or==8 slice) CT angiography may be equivalent, and treatment algorithms are evaluated. It is noted that change in the diagnosis and management of this injury constellation is rapid due to technological advancement and the difficulties inherent in performing randomized prospective trials in this patient population.
在美国,因创伤住院的患者中,约每1000人中有1人(0.1%)被诊断为颈动脉或椎动脉钝性损伤(钝性脑血管损伤[BCVI]),其中大多数损伤是在继发于中枢神经系统缺血的症状出现后才被诊断出来的,由此导致的神经功能障碍发病率高达80%,相关死亡率高达40%。通过筛查,所有钝性创伤患者中的发病率升至1%,而损伤严重程度评分≥16分的患者中这一比例高达2.7%。东部创伤外科学会组织实践管理指南委员会着手制定一份关于BCVI筛查、诊断和治疗的循证医学指南。
利用1965年至2005年(含)的文献,对美国国立医学图书馆/国立卫生研究院的Medline数据库进行计算机检索。对标题和摘要进行审查以确定相关性,排除孤立的病例报告、小病例系列、社论、给编辑的信以及综述文章。对所得全文文章的参考文献进行检索以查找其他相关文献,并根据需要获取这些文献。基于以下问题对这些论文进行审查:1. 哪些患者风险足够高,以至于应进行诊断评估以筛查和诊断BCVI?2. 用于筛查和诊断BCVI的合适方式是什么?3. 应如何治疗BCVI?4. 如果有指征,抗血栓治疗应持续多长时间?5. 应如何监测治疗反应?
选择了179篇文章进行审查,其中68篇符合纳入标准,摘录于所附的证据表中并用于提出建议。
东部实践管理指南委员会提出了对BCVI进行筛查、诊断和治疗应安全有效的指南。确定了筛查的风险因素(见……),审查了筛查方式,表明尽管血管造影术仍是金标准,但多平面(≥8层)CT血管造影术可能与之相当,并评估了治疗算法。需要注意的是,由于技术进步以及在该患者群体中进行随机前瞻性试验存在固有的困难,这种损伤类型的诊断和管理变化迅速。